|
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data |
|
|
|
Titel: |
Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data |
Auteur: |
Disse, Emmanuel Aron-Wisnewsky, Judith Jacobi, David Clément, Karine Laville, Martine Gauthier, Cyril Pattou, François Molleville, Julie Akerib, Melissa Jubin, Lysiane Gatta-Cherifi, Blandine Gaborit, Bénédicte Montastier, Emilie Stenard, Fabien Carette, Claire Achamrah, Najate Avignon, Antoine Czernichow, Sébastien |
Verschenen in: |
Diabetes & metabolism |
Paginering: |
Jaargang 51 () nr. 3 pagina's p. |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
Elsevier Masson SAS |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|